Schueler, J.; Tschuch, C.; Klingner, K.; Bug, D.; Peille, A.-L.; de Koning, L.; Oswald, E.; Klett, H.; Sommergruber, W.
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization. Cells 2019, 8, 740.
https://doi.org/10.3390/cells8070740
AMA Style
Schueler J, Tschuch C, Klingner K, Bug D, Peille A-L, de Koning L, Oswald E, Klett H, Sommergruber W.
Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization. Cells. 2019; 8(7):740.
https://doi.org/10.3390/cells8070740
Chicago/Turabian Style
Schueler, Julia, Cordula Tschuch, Kerstin Klingner, Daniel Bug, Anne-Lise Peille, Leanne de Koning, Eva Oswald, Hagen Klett, and Wolfgang Sommergruber.
2019. "Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization" Cells 8, no. 7: 740.
https://doi.org/10.3390/cells8070740
APA Style
Schueler, J., Tschuch, C., Klingner, K., Bug, D., Peille, A.-L., de Koning, L., Oswald, E., Klett, H., & Sommergruber, W.
(2019). Induction of Acquired Resistance towards EGFR Inhibitor Gefitinib in a Patient-Derived Xenograft Model of Non-Small Cell Lung Cancer and Subsequent Molecular Characterization. Cells, 8(7), 740.
https://doi.org/10.3390/cells8070740